This downregulated expression of FOXN3 in AML was validated by analysing the online Bloodpool data set (www.bloodspot.eu), revealing that FOXN3 expression was significantly lower in AML than in CD34+ HSCs. The gene discussed is CD34; the disease is acute myeloid leukemia.